Filing Flows › Royalty Pharma (RPRX) › How it makes money
How Royalty Pharma (RPRX) makes money
Royalty Pharma (RPRX) made $690M of revenue in the third quarter 2026 (Q3 2026), +13% from a year earlier. Income from financial royalty assets brought in $648M (94%); Other royalty income and revenues brought in $42.5M (6%). Of every dollar of revenue, 60¢ was left as operating profit, 21¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Income from financial royalty assets | $648M | 93.8% | +2% | +12% |
| Other royalty income and revenues | $42.5M | 6.2% | +18% | +39% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $690M | 100.0% |
| Operating profit | $411M | 59.5% |
| Net earnings | $145M | 21.0% |
| Operating cash flow | $686M | 99.4% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $690M | +13% |
| Q2 2026 | $674M | +16% |
| Q1 2026 | $631M | +11% |
| Q4 2025 | $622M | +5% |
| Q3 2025 | $609M | +8% |
| Q2 2025 | $579M | +8% |
| Q1 2025 | $568M | 0% |
From Royalty Pharma's 10-Q filed Nov 4, 2026 (on EDGAR).
Questions
How does Royalty Pharma make money?
Royalty Pharma (RPRX) made $690M of revenue in the third quarter 2026 (Q3 2026), +13% from a year earlier. Income from financial royalty assets brought in $648M (94%); Other royalty income and revenues brought in $42.5M (6%). Of every dollar of revenue, 60¢ was left as operating profit, 21¢ was left as net earnings.
What is Royalty Pharma's biggest business?
Income from financial royalty assets: $648M in the third quarter 2026, 94% of revenue, +12% from a year earlier.
What is Royalty Pharma's profit margin?
Net earnings were $145M, 21.0% of revenue, in the third quarter 2026; the operating margin was 59.5%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.